Biocryst Pharmaceuticals (BCRX) Gross Margin: 2009-2014
Historic Gross Margin for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to 99.11%.
- Biocryst Pharmaceuticals' Gross Margin was N/A to 87.75% in Q3 2015 from the same period last year, while for Sep 2015 it was 95.80%, marking a year-over-year change of. This contributed to the annual value of 99.11% for FY2014, which is 32.00% down from last year.
- As of FY2014, Biocryst Pharmaceuticals' Gross Margin stood at 99.11%, which was down 0.33% from 99.43% recorded in FY2013.
- Over the past 5 years, Biocryst Pharmaceuticals' Gross Margin peaked at 99.86% during FY2010, and registered a low of 99.11% during FY2014.
- Moreover, its 3-year median value for Gross Margin was 99.43% (2013), whereas its average is 99.35%.
- Its Gross Margin has fluctuated over the past 5 years, first soared by 595bps in 2010, then slumped by 32bps in 2014.
- Biocryst Pharmaceuticals' Gross Margin (Yearly) stood at 99.86% in 2010, then reached 99.50% in 2012, then fell by 6bps to 99.43% in 2013, then tumbled by 32bps to 99.11% in 2014.